LRRK2 and Parkinson disease: However, this may be due to non-synuclein pathology in some LRRK2-associated PD, which is known to have a variable neuropathological basis or differences in the seeding propensity of LRRK2-associated α-synuclein strains with currently used substrates (Garrido et al., 2019).